Combination of Liquid-based Cytologic Test & HPV Testing for Better Cervical Cancer Screening

Company news
2021-10-21

With the popularization and promotion of cervical cancer screening, the incidence and mortality rates of cervical cancer are generally decreasing worldwide.

 

Currently, with the continuous advancement, combination of liquid-based cytologic (LBC) test and HPV testing is more commonly used method for cervical cancer screening in some scenarios.

 

According to the recent studies, the combination of two screening methods can reduce the false-negative rate of cervical cancer screening and produce less pain for the patients by avoiding unnecessary colposcopy.

 

Bioperfectus Human Papillomavirus Real Time PCR Kit Human Papillomavirus Genotyping Real Time PCR Kit are making the free upgrading to meet different laboratories’ demands.

 

  • One sample for both HPV and cytologic test
  • Clinical fulfillment: cover up to 21 types of HPV including HPV-16, HPV-18 and others
  • Reliable performance: high sensitivity and specificity validated in clinical sites
  • Easy screening: 100 mins to complete 96 tests

 

MOST READ

Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.

2022-11-30

Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.

2022-11-15

Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).

2022-11-14